193 related articles for article (PubMed ID: 29274237)
41. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
42. Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity.
Veau D; Krykun S; Mori G; Orena BS; Pasca MR; Frongia C; Lobjois V; Chassaing S; Lherbet C; Baltas M
ChemMedChem; 2016 May; 11(10):1078-89. PubMed ID: 27097919
[TBL] [Abstract][Full Text] [Related]
43. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
[TBL] [Abstract][Full Text] [Related]
44. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
46. In Vitro Anti-
Staniszewska M; Kuryk Ł; Gryciuk A; Kawalec J; Rogalska M; Baran J; Łukowska-Chojnacka E; Kowalkowska A
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443595
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS
Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979
[TBL] [Abstract][Full Text] [Related]
48. Preparation and antitubercular activities of alkylated amino alcohols and their glycosylated derivatives.
Taveira AF; Hyaric ML; Reis EF; Araújo DP; Ferreira AP; de Souza MA; Alves LL; Lourenço MC; Vicente FR; de Almeida MV
Bioorg Med Chem; 2007 Dec; 15(24):7789-94. PubMed ID: 17851083
[TBL] [Abstract][Full Text] [Related]
49. [In vitro antimycobacterial activity of a new quinolone, T-3761].
Tomioka H; Sato K; Saito H
Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
[TBL] [Abstract][Full Text] [Related]
50. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents.
Desai NC; Trivedi AR; Somani HC; Bhatt KA
Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154
[TBL] [Abstract][Full Text] [Related]
51. Search of antitubercular activities in tetrahydroacridines: synthesis and biological evaluation.
Tripathi RP; Verma SS; Pandey J; Agarwal KC; Chaturvedi V; Manju YK; Srivastva AK; Gaikwad A; Sinha S
Bioorg Med Chem Lett; 2006 Oct; 16(19):5144-7. PubMed ID: 16870429
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.
Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and Tuberculostatic Activity Evaluation of Novel Benzazoles with Alkyl, Cycloalkyl or Pyridine Moiety.
Krause M; Foks H; Augustynowicz-Kopeć E; Napiórkowska A; Szczesio M; Gobis K
Molecules; 2018 Apr; 23(4):. PubMed ID: 29690646
[TBL] [Abstract][Full Text] [Related]
55. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
Jaso A; Zarranz B; Aldana I; Monge A
J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
[TBL] [Abstract][Full Text] [Related]
56. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives.
Patel KN; Telvekar VN
Eur J Med Chem; 2014 Mar; 75():43-56. PubMed ID: 24530490
[TBL] [Abstract][Full Text] [Related]
58. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
59. Anti-
Palos I; Luna-Herrera J; Lara-Ramírez EE; Loera-Piedra A; Fernández-Ramírez E; Aguilera-Arreola MG; Paz-González AD; Monge A; Wan B; Franzblau S; Rivera G
Molecules; 2018 Jun; 23(6):. PubMed ID: 29914062
[TBL] [Abstract][Full Text] [Related]
60. New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis.
Giacobbo BC; Pissinate K; Rodrigues-Junior V; Villela AD; Grams ES; Abbadi BL; Subtil FT; Sperotto N; Trindade RV; Back DF; Campos MM; Basso LA; Machado P; Santos DS
Eur J Med Chem; 2017 Jan; 126():491-501. PubMed ID: 27914363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
